Rina Kansal | Medicine and Dentistry | Best Researcher Award
University at Buffalo | United States
Dr. Rina Kansal, M.D., is an accomplished physician-scientist with extensive expertise in molecular oncology, genetics, and hematopathology. She has served in diverse academic and clinical leadership roles at prestigious institutions including the University of Michigan, SUNY Buffalo, Medical College of Wisconsin, Cedars-Sinai Medical Center, Pennsylvania State University, and the Versiti Blood Center of Wisconsin. Over her career, Dr. Kansal has combined clinical practice, laboratory diagnostics, and academic teaching with a strong emphasis on advancing precision medicine. Her contributions span across hematopathology, molecular pathology, and genetic testing, where she has played a pivotal role in integrating cutting-edge diagnostics into patient care. In addition to her clinical leadership, she has maintained continuous scholarly activity aimed at enhancing medical education and translational research. With certifications from the American Board of Pathology and the American Board of Medical Genetics and Genomics, she exemplifies a career committed to advancing pathology and medical education.
Publication Profile
Orcid
Education
Dr. Kansal’s medical education began at Maulana Azad Medical College, University of Delhi, India, where she earned her M.B.B.S. degree. She further strengthened her global qualifications by completing the Professional and Linguistic Assessment Board Examination in the U.K. and achieving M.R.C.P. Part 1 certification in Internal Medicine from the Royal College of Physicians, Edinburgh. After immigrating to the United States, she successfully cleared USMLE Steps 1 and 2, becoming certified by the Educational Commission for Foreign Medical Graduates. She completed her residency in Anatomic and Clinical Pathology at SUNY Buffalo and pursued advanced fellowships in oncologic pathology (Roswell Park Cancer Institute, hematopathology (University of Michigan, and molecular genetic pathology (UCLA. She is diplomate of the American Board of Pathology in Anatomic, Clinical, and Hematologic Pathology and holds certification in Molecular Genetic Pathology. she completed Medical Education Research Certification through the AAMC.
Experience
Dr. Kansal’s professional journey spans several decades, integrating academic, clinical, and administrative excellence. She began as an Instructor of Anatomy at Maulana Azad Medical College before transitioning to the United Kingdom as a Senior House Officer and Registrar. In the U.S., she advanced through residency and faculty positions, becoming Assistant Professor at SUNY Buffalo and later Director of Hematopathology and Flow Cytometry at the Medical College of Wisconsin. She gained further experience at Cedars-Sinai Medical Center as Staff Hematopathologist and Visiting Scientist. At Penn State Hershey Medical Center, she served as Associate Professor of Pathology before joining Versiti Blood Center of Wisconsin as Associate Medical Director of Molecular Oncology and Genetics. She has dedicated herself to scholarly pursuits, preparing for academic faculty advancement. Across these roles, she has contributed to medical education, research, and diagnostic innovation, mentoring students and improving laboratory practices.
Honors and Awards
Dr. Kansal’s distinguished career is marked by numerous certifications and recognitions reflecting her clinical expertise and commitment to lifelong learning. She is board-certified in Anatomic Pathology, Clinical Pathology, Hematopathology, and Molecular Genetic Pathology, with certifications spanning through. Her global qualifications include medical certifications in India, the United Kingdom, and the United States, demonstrating her international professional standing. She holds the Membership of the Royal College of Physicians (M.R.C.P.), certification from the General Medical Council (U.K.), and American Board diplomate status. Additionally, she earned the Medical Education Research Certification (MERC) from the American Association of Medical Colleges, underscoring her dedication to advancing medical pedagogy. While her formal accolades are primarily board certifications and professional recognitions, her honors are also reflected in the senior academic and leadership positions she has held across prominent medical schools and healthcare institutions, where she has been consistently recognized for her expertise and contributions.
Research Focus
Dr. Kansal’s research focus lies at the intersection of molecular oncology, hematopathology, and precision diagnostics. Her work emphasizes the use of molecular genetic pathology to better understand and classify hematologic malignancies, solid tumors, and genetic disorders. Through her clinical and research roles, she has explored applications of molecular techniques such as cytogenetics, flow cytometry, and next-generation sequencing in diagnosing complex cancers. At UCLA, during her fellowship and subsequent research year, she contributed to advancing molecular diagnostics and translational research in cancer genomics. Her scholarly pursuits also extend into medical education research, reflected in her MERC certification, aiming to improve teaching methodologies for pathology and laboratory medicine. With expertise spanning multiple sub-specialties of pathology, Dr. Kansal has consistently worked to bridge laboratory innovations with clinical outcomes. Her ongoing academic interests include expanding the role of genomic testing in personalized medicine and integrating evidence-based approaches into pathology education and practice.
Publications
-
Research Progress in Hematological Malignancies: A Molecular Genetics Perspective
-
Rapid Whole-Genome Sequencing in Critically Ill Infants and Children with Suspected, Undiagnosed Genetic Diseases: Evolution to a First-Tier Clinical Laboratory Test in the Era of Precision Medicine
-
Is It Time to Assess T Cell Clonality by Next-Generation Sequencing in Mature T Cell Lymphoid Neoplasms? A Scoping Review (Journal of Molecular Pathology)
-
The Placement of Auer Rods as a Single Diagnostic Criterion for the Highest-Risk Category of Myelodysplastic Syndromes: A Single-Institution Study and Critical Analysis
-
The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
Conclusion
In conclusion, Dr. Rina Kansal stands as a highly accomplished physician, educator, and researcher with an exceptional record of achievement in pathology, molecular genetics, and oncology. Her career trajectory, spanning continents and premier academic institutions, reflects her adaptability and dedication to advancing patient care through innovation in diagnostics and medical education. With board certifications in multiple sub-disciplines of pathology and extensive experience in both clinical practice and research, she has continually contributed to the evolution of precision medicine. Her educational achievements, professional leadership roles, and continuous pursuit of scholarly activities underscore her commitment to excellence. Beyond her clinical and academic expertise, Dr. Kansal’s focus on teaching, mentoring, and advancing medical education distinguishes her as a leader preparing the next generation of pathologists. Her career exemplifies the integration of scientific rigor, clinical expertise, and dedication to advancing healthcare through research, diagnostics, and education.